window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    AI-derived drug candidate reduces fentanyl intake in preclinical opioid study

    A study published in Proceedings of the National Academy of [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    SonoNeu exits stealth as part of $41.3M ARPA-H programme to advance sonogenetics

    SonoNeu has emerged from stealth as part of a $41.3m [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    AC Immune amends Lilly collaboration on Tau small molecules for Alzheimer’s disease

    AC Immune has amended its collaboration agreement with Eli Lilly [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas

    Anixa Biosciences advances breast cancer vaccine toward Phase 2 with Cytovance manufacturing deal

    Anixa Biosciences is advancing its breast cancer vaccine programme towards [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Cereno Scientific reports long-term safety data from CS1 pulmonary arterial hypertension program

    Cereno Scientific has reported initial long-term safety findings from a [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    City St George’s and Paradigm Biopharmaceuticals study osteoarthritis pain drug mechanism

    City St George’s, University of London has partnered with Paradigm [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Nanotube injector enables controlled cytoplasmic transfer between living cells

    Researchers in Japan have developed a nanotube-based system that enables [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain

    Thermo Fisher launches Glacios 3 cryo-TEM to expand access to structural biology imaging

    Thermo Fisher Scientific has launched the Thermo Scientific Glacios 3 [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    PRISM ALS initiative develops patient-derived stem cell models to improve ALS/MND drug discovery

    A new global initiative aims to address long-standing limitations in [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development

    Proxygen appoints Chiara Conti as chief scientific officer to support move into clinical-stage development

    Proxygen has appointed Chiara Conti as chief scientific officer, as [...]

    May 5, 2026
Previous345Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • FairJourney Bio opens cryo-EM facility in San Diego for antibody discovery
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Manufacturing & Supply Chain
  • Kinesin-2 motor variants shown to control cargo transport in neurons
    Categories: Drug Discovery & Development, Therapeutic Areas
  • Emalex secures US patent for ecopipam orally disintegrating tablet in Tourette syndrome
    Categories: Central Nervous System, Clinical & Regulatory, Drug Delivery & Formulation, Drug Discovery & Development, Opinion & Events, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top